Scott A Davis

Summary

Publications

  1. ncbi Top dermatologic conditions in patients of color: an analysis of nationally representative data
    Scott A Davis
    Department of Dermatology, Wake Forest School of Medicine, Winston Salem, NC 27157 1071, USA
    J Drugs Dermatol 11:466-73. 2012
  2. ncbi Use of topical antibiotics as prophylaxis in clean dermatologic procedures
    Michelle M Levender
    Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1071, USA
    J Am Acad Dermatol 66:445-51. 2012
  3. ncbi Trends in the use of topical over the counter products in the management of dermatologic disease in the United States
    Bridgit V Nolan
    Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA
    Dermatol Online J 18:1. 2012
  4. ncbi Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey
    Erin T Landis
    Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Medical Center Boulevard, Winston Salem, NC, USA
    J Dermatolog Treat 23:272-7. 2012
  5. ncbi Practice trends in the treatment of actinic keratosis in the United States: 0.5% fluorouracil and combination cryotherapy plus fluorouracil are underused despite evidence of benefit
    Thomas J Hagele
    Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston Salem, NC 27157 1071, USA
    J Cutan Med Surg 16:107-14. 2012
  6. ncbi Treatment of impetigo: oral antibiotics most commonly prescribed
    Ranti S Bolaji
    Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1071, USA
    J Drugs Dermatol 11:489-94. 2012
  7. ncbi Services available and their effectiveness
    Christine Ahn
    Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157 1071, USA
    Dermatol Clin 30:19-37, vii. 2012
  8. ncbi Sticker charts: a method for improving adherence to treatment of chronic diseases in children
    Kara Luersen
    Departments of Dermatology, School of Medicine, Wake Forest University, Winston Salem, North Carolina 27157, USA
    Pediatr Dermatol 29:403-8. 2012
  9. ncbi Topical antibiotic trends from 1993 to 2007: use of topical antibiotics for non-evidence-based indications
    Whitney J Lapolla
    Department of Dermatology, Center for Dermatology Research, School of Medicine, Wake Forest University, Winston Salem, North Carolina, USA
    Dermatol Surg 37:1427-33. 2011
  10. ncbi The effect of reminder systems on patients' adherence to treatment
    Sarah D Fenerty
    Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA
    Patient Prefer Adherence 6:127-35. 2012

Collaborators

  • Michelle M Levender
  • Brad A Yentzer
  • Amy J McMichael
  • Steven R Feldman
  • Kara Luersen
  • Alan B Fleischer
  • Ranti S Bolaji
  • Christine Ahn
  • Bridgit V Nolan
  • Thomas J Hagele
  • Tushar S Dabade
  • Sarah D Fenerty
  • Ashley N Feneran
  • Erin T Landis
  • Sebastian G Kaplan
  • Phillip M Williford
  • Whitney J Lapolla
  • Daniel P Krowchuk
  • Woodrow W Winchester
  • Cameron West
  • Karen R Gerancher
  • Cheryl J Gustafson
  • Troy D Abel

Detail Information

Publications10

  1. ncbi Top dermatologic conditions in patients of color: an analysis of nationally representative data
    Scott A Davis
    Department of Dermatology, Wake Forest School of Medicine, Winston Salem, NC 27157 1071, USA
    J Drugs Dermatol 11:466-73. 2012
    ..Some dermatologic disorders are known to be much more common in patients of color, but the leading dermatologic disorders in patients of color have not yet been described on the basis of nationally representative data...
  2. ncbi Use of topical antibiotics as prophylaxis in clean dermatologic procedures
    Michelle M Levender
    Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1071, USA
    J Am Acad Dermatol 66:445-51. 2012
    ..Topical antibiotics are not indicated for routine postoperative care in clean dermatologic procedures, but may be widely used...
  3. ncbi Trends in the use of topical over the counter products in the management of dermatologic disease in the United States
    Bridgit V Nolan
    Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA
    Dermatol Online J 18:1. 2012
    ..Over the counter (OTC) products play an important role in treating and preventing disease in the U.S. Topical OTCs are widely used but use in dermatology is not well defined...
  4. ncbi Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey
    Erin T Landis
    Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Medical Center Boulevard, Winston Salem, NC, USA
    J Dermatolog Treat 23:272-7. 2012
    ....
  5. ncbi Practice trends in the treatment of actinic keratosis in the United States: 0.5% fluorouracil and combination cryotherapy plus fluorouracil are underused despite evidence of benefit
    Thomas J Hagele
    Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston Salem, NC 27157 1071, USA
    J Cutan Med Surg 16:107-14. 2012
    ..Evidence shows that 0.5% fluorouracil has similar efficacy and is better tolerated than 5% fluorouracil. Evidence also shows that combination therapy with cryosurgery and fluorouracil is beneficial...
  6. ncbi Treatment of impetigo: oral antibiotics most commonly prescribed
    Ranti S Bolaji
    Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1071, USA
    J Drugs Dermatol 11:489-94. 2012
    ..Impetigo is a highly contagious, superficial skin disease that is frequently seen in children. While data support the use of topical antibiotics for treatment, the medications actually prescribed in practice are not well documented...
  7. ncbi Services available and their effectiveness
    Christine Ahn
    Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157 1071, USA
    Dermatol Clin 30:19-37, vii. 2012
    ....
  8. ncbi Sticker charts: a method for improving adherence to treatment of chronic diseases in children
    Kara Luersen
    Departments of Dermatology, School of Medicine, Wake Forest University, Winston Salem, North Carolina 27157, USA
    Pediatr Dermatol 29:403-8. 2012
    ..This may be an effective means to encourage children with atopic dermatitis to apply their medications and improve clinical outcomes...
  9. ncbi Topical antibiotic trends from 1993 to 2007: use of topical antibiotics for non-evidence-based indications
    Whitney J Lapolla
    Department of Dermatology, Center for Dermatology Research, School of Medicine, Wake Forest University, Winston Salem, North Carolina, USA
    Dermatol Surg 37:1427-33. 2011
    ..Systemic antibiotic use has become more conservative with the emergence of drug resistance. Topical antibiotics are employed for a variety of indications, although there are only a few evidence-based indications...
  10. ncbi The effect of reminder systems on patients' adherence to treatment
    Sarah D Fenerty
    Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA
    Patient Prefer Adherence 6:127-35. 2012
    ..Patient adherence is an important component of the treatment of chronic disease. An understanding of patient adherence and its modulating factors is necessary to correctly interpret treatment efficacy and barriers to therapeutic success...